Overview

Accelerating Gastrointestinal Recovery

Status:
Completed

Trial end date:
2015-10-01

Target enrollment:

Participant gender:

Summary

This study is designed to determine whether an oral perioperative medication (alvimopan--a selective mu antagonist) improves bowel recovery over placebo after surgery for ovarian cancer.

Phase:

Phase 3

Details

Lead Sponsor:

Jamie N. Bakkum-Gamez

Collaborator:

Cubist Pharmaceuticals LLC

Treatments:

Alvimopan